HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick G Gavin Selected Research

Interferon Type I

4/2024Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick G Gavin Research Topics

Disease

10Neoplasms (Cancer)
10/2020 - 03/2010
8Breast Neoplasms (Breast Cancer)
10/2020 - 12/2013
5Colonic Neoplasms (Colon Cancer)
02/2024 - 03/2010
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018 - 01/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2024
1Dysbiosis
01/2021
1Infections
01/2021
1Pathologic Complete Response
12/2019
1Diarrhea
12/2019
1Disease Progression
10/2018
1Inflammation (Inflammations)
10/2018
1Microsatellite Instability
12/2012

Drug/Important Bio-Agent (IBA)

8Trastuzumab (Herceptin)FDA Link
10/2020 - 12/2013
6B 31IBA
10/2020 - 12/2013
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024 - 12/2012
3neratinibIBA
01/2021 - 12/2019
3Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 03/2017
2Leucovorin (Folinic Acid)FDA Link
02/2024 - 09/2016
2Fluorouracil (Carac)FDA LinkGeneric
02/2024 - 09/2016
2Hormones (Hormone)IBA
12/2019 - 12/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 03/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 03/2017
2Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2015
1anifrolumabIBA
04/2024
1Interferon Type IIBA
04/2024
1Volatile Fatty AcidsIBA
01/2021
1Acetates (Acetic Acid Esters)FDA Link
01/2021
1Panitumumab (Vectibix)FDA Link
01/2021
1Cetuximab (Erbitux)FDA Link
01/2021
1Butyrates (Butyrate)IBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
10/2020
1Estrogen ReceptorsIBA
10/2020
1ErbB Receptors (EGF Receptor)IBA
12/2019
1AutoantibodiesIBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1AntigensIBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1human ERBB2 proteinIBA
04/2015
1Formaldehyde (Formol)FDA Link
03/2010
1ParaffinIBA
03/2010
1NucleotidesIBA
03/2010

Therapy/Procedure

8Therapeutics
02/2024 - 04/2015
7Drug Therapy (Chemotherapy)
10/2020 - 09/2016
1Adjuvant Chemotherapy
12/2019
1Investigational Therapies (Experimental Therapy)
09/2016